These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3050539)

  • 21. Not every prostate cancer needs to be treated. The place for expectant management.
    Griffin AS; O'Rourke ME
    N C Med J; 1999; 60(5):261-7. PubMed ID: 10495654
    [No Abstract]   [Full Text] [Related]  

  • 22. An analysis of watchful waiting for clinically localized prostate cancer.
    Steinberg GD; Bales GT; Brendler CB
    J Urol; 1998 May; 159(5):1431-6. PubMed ID: 9554328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Re: Multivitamin use and risk of prostate cancer in the National Institutes of Health-AARP Diet and Health Study.
    Hickey S; Noriega L; Roberts H
    J Natl Cancer Inst; 2007 Oct; 99(19):1491-2; author reply 1492-3. PubMed ID: 17895477
    [No Abstract]   [Full Text] [Related]  

  • 24. Conservative management of clinically-localized prostate cancer.
    Chodak G
    Can J Oncol; 1994 Nov; 4 Suppl 1():20-1; discussion 22-3. PubMed ID: 8853484
    [No Abstract]   [Full Text] [Related]  

  • 25. "Short- and long-term mortality with localized prostate cancer": errors and omissions?
    Roach M
    Arch Intern Med; 2008 Jun; 168(12):1351; author reply 1353. PubMed ID: 18574095
    [No Abstract]   [Full Text] [Related]  

  • 26. Adjuvant chemotherapy for breast cancer. National Institutes of Health Consensus Development Conference Statement.
    Natl Inst Health Consens Dev Conf Consens Statement; 1985; 5(12):5 p.. PubMed ID: 3908920
    [No Abstract]   [Full Text] [Related]  

  • 27. Health implications of obesity. National Institutes of Health Consensus Development Conference Statement.
    Natl Inst Health Consens Dev Conf Consens Statement; 1985; 5(9):1-7. PubMed ID: 3889597
    [No Abstract]   [Full Text] [Related]  

  • 28. NIH Consensus Development Conference summary: Adjuvant Chemotherapy of Breast Cancer.
    J Tenn Med Assoc; 1981 Mar; 74(3):190-2. PubMed ID: 7024644
    [No Abstract]   [Full Text] [Related]  

  • 29. Best practice statement on cryosurgery for the treatment of localized prostate cancer.
    Babaian RJ; Donnelly B; Bahn D; Baust JG; Dineen M; Ellis D; Katz A; Pisters L; Rukstalis D; Shinohara K; Thrasher JB
    J Urol; 2008 Nov; 180(5):1993-2004. PubMed ID: 18817934
    [No Abstract]   [Full Text] [Related]  

  • 30. Outcome based staging for clinically localized adenocarcinoma of the prostate.
    D'Amico AV; Whittington R; Schultz D; Malkowicz SB; Tomaszewski JE; Wein A
    J Urol; 1997 Oct; 158(4):1422-6. PubMed ID: 9302135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pretreatment staging of clinically localized prostate cancer. American College of Radiology. ACR Appropriateness Criteria.
    Amis ES; Bigongiari LR; Bluth EI; Bush WH; Choyke PL; Fritzsche P; Holder L; Newhouse JH; Sandler CM; Segal AJ; Resnick MI; Rutsky EA
    Radiology; 2000 Jun; 215 Suppl():703-8. PubMed ID: 11037488
    [No Abstract]   [Full Text] [Related]  

  • 32. National Institutes of Health Consensus Development Conference consensus statement. The use of diagnostic ultrasound imaging in pregnancy.
    Ultrasound Med Biol; 1984; 10(4):547-56. PubMed ID: 6390907
    [No Abstract]   [Full Text] [Related]  

  • 33. Health implications of obesity. National Institutes of Health Consensus Development Conference Statement.
    Ann Intern Med; 1985 Dec; 103(6 ( Pt 2)):1073-77. PubMed ID: 4062128
    [No Abstract]   [Full Text] [Related]  

  • 34. National Institutes of Health Consensus Development Conference Statement: Dental Implants. June 13-15, 1988.
    Int J Oral Implantol; 1988; 5(1):13-20. PubMed ID: 3078243
    [No Abstract]   [Full Text] [Related]  

  • 35. National Institutes of Health Consensus Development Conference statement on dental implants June 13-15, 1988.
    J Dent Educ; 1988 Dec; 52(12):824-7. PubMed ID: 3057028
    [No Abstract]   [Full Text] [Related]  

  • 36. The search for better prognostic factors for men treated for localized prostate cancer continues.
    Karakiewicz PI; Suardi N; Shariat SF
    Eur Urol; 2008 Apr; 53(4):689-90. PubMed ID: 18093722
    [No Abstract]   [Full Text] [Related]  

  • 37. Erectile function outcome reporting after clinically localized prostate cancer treatment.
    Burnett AL; Aus G; Canby-Hagino ED; Cookson MS; D'Amico AV; Dmochowski RR; Eton DT; Forman JD; Goldenberg SL; Hernandez J; Higano CS; Kraus S; Liebert M; Moul JW; Tangen C; Thrasher JB; Thompson I;
    J Urol; 2007 Aug; 178(2):597-601. PubMed ID: 17570435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. National Institutes of Health Consensus Development Conference Statement: breast cancer screening for women ages 40-49, January 21-23, 1997. National Institutes of Health Consensus Developmental Panel.
    J Natl Cancer Inst Monogr; 1997; (22):vii-xviii. PubMed ID: 9709265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Editorial comments: the National Institutes of Health Consensus Development Conference Statement on Dental Implants.
    Misch CE
    Int J Oral Implantol; 1988; 5(1):7-10. PubMed ID: 3078249
    [No Abstract]   [Full Text] [Related]  

  • 40. Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE.
    Harlan SR; Cooperberg MR; Elkin E; Lubeck DP; Meng M; Mehta SS; Carroll PR
    J Urol; 2003 Nov; 170(5):1804-7. PubMed ID: 14532780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.